Hemab Therapeutics
COAG----
全部股东
股东类型
- 风投/私募48.49%
- 机构投资者44.29%
- 对冲基金6.96%
- 个人与内部人士0.26%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
RA Capital Management, L.P. | 16.72% | 780.86 万 | 0.91% | +297.05 万 | |
Access Biotechnology | 10.44% | 487.63 万 | 3.32% | +110.00 万 | |
Novo Holdings A/S | 8.95% | 418.06 万 | 6.28% | +0 | |
FMR LLC | 7.92% | 369.78 万 | -- | +369.78 万 | |
Capital Research and Management Company | 7.72% | 360.39 万 | 0.15% | +144.60 万 | |
Deep Track Capital, LP | 7.71% | 360.21 万 | 0.28% | +140.82 万 | |
Avoro Capital Advisors LLC | 7.06% | 329.82 万 | 0.51% | +150.00 万 | |
Sofinnova Partners SAS | 5.38% | 251.12 万 | 3.27% | +13.75 万 | |
Artal Group S.A. | 4.91% | 229.50 万 | 0.45% | +20.82 万 | |
Odlander, Fredrikson & Co. AB | 4.06% | 189.47 万 | 2.85% | +0 | |
Bain Capital Life Sciences Investors, LLC | 3.53% | 165.00 万 | -- | +165.00 万 | |
JP Morgan Asset Management | 2.43% | 113.29 万 | -- | +113.29 万 | |
Vanguard Capital Management, LLC | 1.91% | 89.33 万 | -- | +89.33 万 | |
T. Rowe Price Group, Inc. | 1.60% | 74.60 万 | -- | +74.60 万 | |
Driehaus Capital Management LLC | 1.53% | 71.58 万 | -- | +71.58 万 | |
Rock Springs Capital Management LP | 1.23% | 57.54 万 | -- | +57.54 万 | |
Bellevue Asset Management AG | 1.18% | 55.00 万 | -- | +55.00 万 | |
Citadel Advisors LLC | 1.12% | 52.35 万 | -- | +52.35 万 | |
BlackRock, Inc. | 0.61% | 28.38 万 | -- | +28.38 万 | |
Deerfield Management Company, L.P. | 0.59% | 27.50 万 | -- | +27.50 万 |